Internship

Co-op – Analytical Development

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Cambridge, MA, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • B.S. or M.S. candidate in biochemistry, chemistry, chemical engineering, or a related field.
  • Ability to work independently and with peers on cross-functional teams.
  • Ability to excel in a fast-paced environment.
  • Independently motivated, organized, and excellent problem-solving abilities.
  • Strong communication and interpersonal skills.
  • Competence with MS Excel and PowerPoint.
Responsibilities
  • Contribute to the development and optimization of analytical methods to characterize raw materials, in-process and finished products of LNP therapeutics.
  • Perform analytical testing, including LC (liquid chromatography), DLS (Dynamic Light Scattering), and UV-Vis spectroscopy.
  • Analyze the purity, stability, and integrity of nucleic acids and lipids within LNP formulations.
  • Collaborate with teams across the organization to advance company objectives.
  • Thoroughly document results in electronic lab notebooks.
  • Present findings to cross-functional teams.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?